Cytostatic and cytotoxic effects of (E)-2′-deoxy-2′-(fluoromethylene)-cytidine on a solid tumor and a leukemia cell line

Acta Biochimica Polonica

Volumn 47, Issue 1, 2000, Pages 165-171

  Grieb, Paweł ^a   Koronkiewicz, Mirosława ^b   Skierski, Janusz S ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Apoptosis; Cytotoxicity; Flow cytometry; Fluoromethylenedeoxycytidine

Indexed keywords

2'-DEOXY-2'-(FLUOROMETHYLENE)CYTIDINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; TEZACITABINE;

ARTICLE; CELL CULTURE; CELL STRAIN HL 60; COLORECTAL TUMOR; DRUG SCREENING; HUMAN; PATHOLOGY; PROMYELOCYTIC LEUKEMIA;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; TUMOR CELLS, CULTURED;

EID: 0033649136     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_4074     Document Type: Article

References (31)

1. Bitonti, A., Dumont, J.A., Bush, T.L., Cashman, E.A., Cross-Doersen, D.E., Wright, P.S., Matthews, D.P., McCarthy, J.R. & Kaplan, D.A. (1994) Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene) cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res. 54, 1485-1490.
2. Bitonti, A.J., Bush, T.L., Lewis, M.T. & Sunkara, P.S. (1995) Response of human colon and prostate xenografts to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase. Anticancer Res. 15, 179-182.
3. Kanazawa, J., Takahashi, T., Gomi, K. & Okabe, M. (1995) Antitumor activity of (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase (abstract). Proc. AACR 36, A2416.
4. Piepmeier, J.M., Rabidou, N., Schold, S.C., Jr, Bitonti, A.J., Prakash, N.J. & Bush, T.L. (1996) In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL-101731, a novel ribonucleoside diphosphate reductase inhibitor. Cancer Res. 56, 359-361.
5. Ross, B.D., Boklye, K. & Chenevert, T.L. (1994) Assessment of the growth and treatment of experimental intracranial gliomas using magnetic resonance imaging and spectroscopy. Sixth International Symposium on Pediatric Neuro-Oncology, Houston, TX, p. 28.
6. Sun, L.Q., Li, Y.X., Guillou, L., Mirimanoff, R.O. & Coucke, P.A. (1997) Antitumor and radiosensitizing effects of (E)-2′-deoxy-2′-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice. Cancer Res. 57, 4023-4028.
7. Takahashi, T., Nakashima, A., Kanazawa, J., Yamaguchi, K., Akinaga, S., Tamaoki, T. & Okabe, M. (1998) Metabolism and ribonucleotide reductase inhibition of (E)-2′-deoxy-2′-2′-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S3 cells. Cancer Chemother. Pharmacol. 41, 268-274.
8. Wright, P.S., Cross-Doersen, D., Th'ng, J.P.H., Guo, X.W., Crissman, H.A., Bradbury, E.M., Montgomery, L.R., Thompson, F.Y., Loudy, D.E., Johnston, J.O. & Bitonti, A.J. (1996) A ribonucleoside reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts. Exp. Cell Res. 222, 54-60.
9. McCarthy, J.R., Matthews, D.P., Stemerick, D.M., Huber, E.W., Bey, P., Lippert, B.J., Snyder, R.D. & Sunkara, P. (1991) Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem. Soc. 113, 7439-7440.
10. McCarthy, J.R. & Sunkara, P.S. (1995) Chemical and structural approaches to rational drug design (Weiner, D.B. & Williams, W.B., eds.) CRC Press, Boca Raton.
11. Yonetani, Y. & Mizukami, T. (1996) Kinetic analysis of inhibition of human ribonucleotide reductase and DNA polymerase alpha by a new anticancer agent (abstract). Proc. AACR 37, A2764.
12. van der Donk, W.A., Yu, G., Silva, D., Stubbe, J., McCarthy, J.R., Jarvi, E.T., Matthews, D.P., Resvick, R.J. & Wagner, E. (1996) Inactivation of ribonucleotide reductase by (E)-2′-fluoromethylene-2′-deoxycytidine 5′-diphosphate: A paradigm for nucleotide mechanism-based inhibitors. Biochemistry 35, 8381-8391.
13. Eriksson, S., Kiedraszuk, B., Munch-Petersen, B., Oberg, B. & Johansson, N.G. (1991) Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Res. Commun. 176, 586-592.
14. Plunkett, W. & Gandhi, V. (1996) Pharmacology of purine nucleoside analogues. Hematol. Cell Therapy 38 (Suppl. 2), S67-S74.
15. Carson, D.A., Wasson, D.B., Esparza, L.M., Carrera, C.J., Kipps, T.J. & Cottam, H.B. (1992) Oral antilymphocytic activity and induction of apoptosis by 2-chloro-2′-arabinofluoro-2′-deoxyadenosine. Proc. Natl. Acad. Sci. U.S.A. 89, 2970-2974.
16. Larsson, R., Fridborg, H., Liliemark, J., Csoka, K., Kristensen, J., de la Torre, M. & Nygren, P. (1994) In vitro activity of 2-chlorodeoxyadenosine in primary cultures of human hematological and solid tumors. Eur. J. Cancer 30A, 1022-1026.
17. Weiss, G.R., Kuhn, J.G., Rizzo, J., Smith, L.S., Rodrigues, G.I., Eckardt, J.R., Burris, H.A., 3rd, Fields, S., VanDenBerg, K. & von Hoff, D.D. (1995) A phase I and pharmacokinetic study of 2-chlorodeoxyadenosine in patients with solid tumors. Cancer Chemother. Pharmacol. 35, 397-402.
18. Arner, E.S. (1996) On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment. Leuk. Lymph. 21, 225-231.
19. Liliemark, J. (1997) The clinical pharmacokinetics of cladribine. Clin. Pharmacokin. 32, 120-131.
20. Eriksson, S., Arner, E., Spasokoukotskaja, T., Wang, L., Karlsson, A., Brosjo, O., Gunven, P., Juliusson, G. & Liliemark, J. (1994) Properties and levels of deoxynucleoside kinases in normal and tumor cells: Implications for chemotherapy. Adv. Enzyme Regul. 34, 13-25.
21. Bridges, C.G., Ahmed, S.P., Sunkara, P.S., McCarthy, J.R. & Tyms, A.S. (1995) The ribonucleotide reductase inhibitor (E)-2′(fluoromethylene)-2′-deoxycytidine (MDL 101,731): A potential topical therapy for herpes simplex virus infection. Antiviral Res. 27, 325-334.
22. Yuan, C.-S., Yeh, J., Liu, S. & Borchardt, R.T. (1993) Mechanism of inactivation of S-adenosylhomocysteine hydrolase by (Z)-4′-5′-didehydro-5′-deoxy-5′-fluoroadenosine. J. Biol. Chem. 268, 17030-17037.
23. Baker, C.H., Banzon, J., Bollinger, J.M., Stubbe, J., Samano, V., Robins, M.J., Lippert, B., Jarvi, E. & Resvick, R. (1991) 2′-Deoxy2′,2′ -difluorocytidine and 2′-deoxy-2′,2′-difluorocytidine-5′-diphosphates: Potent mechanism-based inhibitors of ribonucleotide reductase. J. Med. Chem. 34, 1879-1884.
24. Skierski, J., Koronkiewicz, M. & Grieb, P. (1999) The effects of FMdC on cell cycle of some leukemia cell lines. Cytometry 37, 1-6.
25. Griffig, J., Koob, R. & Blakley, L. (1989) Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res. 49, 6923-6929.
26. Plunkett, W. & Saunders, P.P. (1991) Metabolism and action of purine nucleoside analogs. Pharmacol. Ther. 49, 239-268.
27. Hansen, H.H. (1996) Gemcitabine - a review. Ann. Oncol. 7 (Suppl. 1), 29.
28. Xie, K.C. & Plunett, W. (1996) Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine. Cancer Res. 56, 3030-3037.
29. Waud, W.R., Schmid, S.M., Harrison, S.D., Jr, Secrist, J.A., III & Montgomery, J.A. (1992) Preclinical and antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine. (Abstract) Proc. AACR 33, 545.
30. Montgomery, J.A., Shortnacy-Fower, A.T., Clayton, S.D., Riordan, J.M. & Secrist, J.A., III (1992) Synthesis and biologic activity of 2′-fluoro-2-halo-derivatives of 9-β-D-arabinosylfluoroadenine. J. Med. Chem. 35, 397-401.
31. Xu, Y.-Z., Huang, P. & Plunkett, W, (1995) Functional compartmentation of dCTP pools. Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts. J. Biol. Chem. 270, 631-637.